Abstract:The interaction between macrophages and oxLDL plays a crucial role in the initiation and progression of atherosclerosis. As a key initiator in a number of plaque promoting processes, oxLDL induces variable effects such as cell apoptosis or proliferation. Orphan nuclear receptor Nur77 is potently induced in macrophages by diverse stimuli, suggesting that it is of importance in vascular inflammation resulting in atherosclerosis, but whether Nur77 induction is detrimental or protective is unclear. In our study, we explore the role of Nur77 in the regulation of oxLDL-induced macrophage apoptosis and the signaling pathways that are involved. We found that oxLDL induced Nur77 expression in a dose and time dependent fashion, and cell viability was decreased in parallel. To determine whether Nur77 induction contributes to the loss of cell viability or is a protective mechanism, the effect of Nur77 overexpression was examined. Importantly, Nur77 overexpression inhibited the oxLDL-induced decrease of cell viability, inhibited the production of apoptotic bodies and restored DNA synthesis following oxLDL exposure. Furthermore, we found that Nur77 induction is mediated through the p38 MAPK signaling pathway. After pretreatment with SB203580, cell viability was decreased, the expression of CyclinA2 and PCNA was attenuated and the percentage of cell apoptosis was enhanced. Likewise, Nur77 overexpression increased the expression of the cell cycle genes PCNA and p21, and attenuated the increase in caspase-3. On the other hand, knockdown of Nur77 expression by specific siRNA resulted in the increased expression of caspase 3. The results demonstrate that Nur77 is induced by oxLDL via the p38 MAPK signaling pathway, which is involved in the regulation of cell survival. Nur77 enhanced cell survival via suppressing apoptosis, without affecting cell proliferation of activated macrophages, which may be beneficial in patients with atherosclerosis.

Blocking Ppar Gamma Interaction Facilitates Nur77 Interdiction Of Fatty Acid Uptake And Suppresses Breast Cancer Progression

Dietary Fatty Acids Affect Lipid Metabolism and Estrogen Receptor Expression in N-Methyl-N-Nitrosourea-Induced Rat Mammary Cancer Model

Effect of N-3 and N-6 Polyunsaturated Fatty Acids on Lipid Metabolic Genes and Estrogen Receptor Expression in MCF-7 Breast Cancer Cells.

In Silico Discovery of Stapled Peptide Inhibitor Targeting the Nur77‐PPARγ Interaction and Its Anti‐Breast‐Cancer Efficacy

PKA/Smurf1 signaling-mediated stabilization of Nur77 is required for anticancer drug cisplatin-induced apoptosis

Nuclear Receptor Nur77 Facilitates Melanoma Cell Survival under Metabolic Stress by Protecting Fatty Acid Oxidation.

Nur77 Suppresses Hepatocellular Carcinoma Via Switching Glucose Metabolism Toward Gluconeogenesis Through Attenuating Phosphoenolpyruvate Carboxykinase Sumoylation

Nur77 Deficiency in Mice Accelerates Tumor Invasion and Metastasis by Facilitating TNFα Secretion and Lowering CSF-1R Expression

Regulation of Nur77 expression by β-catenin and its mitogenic effect in colon cancer cells.

Modulation Of The Nur77-Bcl-2 Apoptotic Pathway By P38 Alpha Mapk

Targeting Nur77 Translocation.

Inhibition of Β-Catenin Signaling by Nongenomic Action of Orphan Nuclear Receptor Nur77

Orphan Nuclear Receptor Nur77 Promotes Colorectal Cancer Invasion and Metastasis by Regulating MMP-9 and E-cadherin.

Discovery of 5-(Pyrimidin-2-ylamino)-1h-indole-2-carboxamide Derivatives As Nur77 Modulators with Selective and Potent Activity Against Triple-Negative Breast Cancer.

Nur77 Inhibits Oxldl Induced Apoptosis of Macrophages Via the P38 MAPK Signaling Pathway.

Peroxisome Proliferator Activated Receptor Alpha Inhibits Hepatocarcinogenesis Through Mediating NF-κB Signaling Pathway.

A Unique Pharmacophore for Activation of the Nuclear Orphan Receptor Nur77 in Vivo and in Vitro

Dual roles of Nur77 in selective regulation of apoptosis and cell cycle by TPA and ATRA in gastric cancer cells.

Nur77: a Potential Therapeutic Target in Cancer

Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism

[Nur77 inhibits the proliferation of prostate cancer cells].